Valeant is on track to reduce about $5 billion of debt. But it has more than $27 billion to go By: MarketWatch August 08, 2017 at 12:39 PM EDT The company will face a debt “wall” starting with more than $5 billion due in 2020. Read More >> Related Stocks: Standard & Poors 500 Valeant Pharmaceuticals International, Inc.